Cytel Inc

About Cytel Inc

Cytel Inc is a leading global provider of innovative statistical software and services for the pharmaceutical and biotechnology industries. Established with a vision to enhance the efficiency of clinical trials, Cytel has been at the forefront of developing advanced methodologies that streamline the drug development process.

With a strong commitment to quality and excellence, Cytel offers a range of solutions including statistical consulting, software development, and data analytics. Their flagship product, East, is widely recognized for its capabilities in designing and analysing clinical trials, helping clients make informed decisions based on robust statistical evidence.

The company prides itself on its team of experienced statisticians and data scientists who work collaboratively with clients to tailor solutions that meet their specific needs. Cytel’s expertise extends across various therapeutic areas, ensuring that they can support a diverse portfolio of projects.

In addition to their software offerings, Cytel provides comprehensive training and support services, empowering clients to leverage their tools effectively. The company is dedicated to fostering innovation and continuously invests in research and development to stay ahead of industry trends.

As a socially responsible organisation, Cytel is committed to ethical practices and strives to contribute positively to the communities in which it operates. Their mission is to accelerate the delivery of life-saving therapies to patients worldwide, making a meaningful impact on global health.

With headquarters in the UK, Cytel Inc is strategically positioned to serve clients across Europe and beyond, reinforcing its status as a trusted partner in the biopharmaceutical sector.